• Suresh G Dhone
• Dr. R. K. Godge
• M. S. Bhosale

Capmatinib is the first FDA-approved therapy for the treatment of non-small cell lung cancer cells with specific mutations (leading to a mesenchymal-epithelial junction such as exon 14 MET skipping). This work classifies a new rapid, accurate, and accurate analytical method for the determination of capmatinib in most and indeterminate amounts of pharmaceutical products. Analytical techniques play an important role in providing solutions such as development. This article will provide an overview and classification of the various analytical methods most commonly used to identify common supply problems. Pharmaceutical analysis has a unique role in quality assurance as well as in the internal control of most pharmaceutical drugs and preparations. The rapid rise of the pharmaceutical and pharmaceutical industries in many parts of the world has led to an increase in demand for new analytical methods in the pharmaceutical industry. As a result, the development of analytical methodology has become an important learning activity. Recent advances in analytical methods have resulted from advances in analytical tools.

Introduction of Capmatinib, Pharmacology, Pharmacokinetics, HPLC Method.

"A REVIEW ON ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CAPMATINIB IN BULK AND DOSAGE FORM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.9, Issue 1, page no.e5-e9, January-2022, Available :http://www.jetir.org/papers/JETIR2201402.pdf

"A REVIEW ON ANALYTICAL METHOD DEVELOPMENT AND VALIDATION OF CAPMATINIB IN BULK AND DOSAGE FORM", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.9, Issue 1, page no. ppe5-e9, January-2022, Available at : http://www.jetir.org/papers/JETIR2201402.pdf